Extensively Drug-Resistant Typhoid Fever in the United States
- PMID: 34917695
- PMCID: PMC8669042
- DOI: 10.1093/ofid/ofab572
Extensively Drug-Resistant Typhoid Fever in the United States
Abstract
Cases of extensively drug-resistant (XDR) typhoid fever have been reported in the United States among patients who did not travel internationally. Clinicians should consider if and where the patient traveled when selecting empiric treatment for typhoid fever. XDR typhoid fever should be treated with a carbapenem, azithromycin, or both.
Keywords: Pakistan; Salmonella Typhi infection; drug resistance; enteric fever; microbial; treatment.
Published by Oxford University Press on behalf of Infectious Diseases Society of America 2021.
Figures

References
-
- Centers for Disease Control and Prevention. Typhoid fever and paratyphoid fever. Available at: https://www.cdc.gov/typhoid-fever/index.html. Accessed 16 March 2021.
-
- Osler W. The Principles and Practice of Medicine: Designed for the Use of Practitioners and Students of Medicine. 8th ed. D Appleton and Company; 1912.
-
- Stuart BM, Pullen RL.. Typhoid: clinical analysis of three hundred and sixty cases. ArchIntern Med 1946; 78:629–61. - PubMed